Evaluation of Low Dose Laser in Treatment of Tinnitus

The purpose of this study is to determine wether low dose laser is effective on idiopathic subjective tinnitus.

Completed

Looking for future studies?

Key information

Conditions

Subjective Tinnitus Ear Diseases Hearing Disorders Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Pathological Conditions, Signs and Symptoms Sensation Disorders Signs and Symptoms Tinnitus

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults older than 18 years old
Idiopathic, subjective, unilateral tinnitus with at least 2 month duration

Exclusion criteria

Patients with chronic otitis media
Patients with tympan perforation with any underlying cause
Patients with external otitis
Patients with tinnitus related to a retrocochlear lesion or other known lesions of the ear

Treatment and study plan

Low dose laser

Radiation

5mv laser with a wavelength of 650nm

Placebo

Radiation

The act of radiating laser to the ear is done while the set is off.

Sponsors and collaborators

Lead sponsor

Islamic Azad University of Mashhad

Other

Registry information

Official study title

Phase 1 Evaluation of Low Dose Laser in Treatment of Tinnitus

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Dec 30, 2010
Registry last updated: Dec 30, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed